Huntsman Cancer Institute joins innovative clinical trials program for blood cancers

Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials program designed to match patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) with a clinical trial specifically designed for the genetic signature of their disease.

Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors

SAN ANTONIO — Women ages >50 who de-escalated to less-frequent mammography 3 years after curative surgery for early-stage breast cancer had similar outcomes to women

December 10, 2023

How A Human-AI Partnership Can Boost Clinical Trial Recruitment

The demand for clinical trial testing is rising, from over 260,000 trials conducted in 2018 to nearly double that figure in 2024. This means that more trials are being conducted

October 23, 2024

With little fanfare, Biden administration stacked vaccine advisory committee with new members

Before leaving office, President Biden’s health secretary approved the appointments of eight new candidates to a critical committee that helps set U.S. vaccination policy — a

January 31, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.